Results 91 to 100 of about 14,294,829 (187)

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Mechanisms of Rejection of High Grade B cell Lymphoma in Mice [PDF]

, 2008
The incidence of high grade B cell lymphoma in western countries has increased over the last decades. Improvement of conventional chemotherapy regimens has significantly contributed to prolonged 5-year survival rates which currently reach around 60 ...
Sukumar, Madhusudhanan
core   +1 more source

Angioimmunoblastic T cell lymphoma

Indian Journal of Dermatology, Venereology, and Leprology, 2015
Yuranga Weerakkody, Daniel Bell, Yaïr Glick   +2 more
openaire   +2 more sources

Real‐World Data on the p.Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas

Cancer Medicine
Background T follicular helper (Tfh) cell lymphomas, including their most prevalent form, angioimmunoblastic T‐cell lymphoma, frequently present with clinical symptoms, such as fever and rash, accompanied by substantial immune cell infiltration within ...
Yuri Tsuboi, Keiichiro Hattori, Naoki Kurita, Yasuhito Suehara, Toru Nanmoku, Ryota Matsuoka, Ryota Ishii, Sakurako Suma, Kenichi Makishima, Yumiko Maruyama, Tatsuhiro Sakamoto, Takayasu Kato, Hidekazu Nishikii, Naoshi Obara, Daisuke Matsubara, Mamiko Sakata‐Yanagimoto   +15 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study

, 2010
Angioimmunoblastic T-cell lymphoma is known to frequently involve bone marrow. However, the histologic and immunophenotypic features of angioimmunoblastic T-cell lymphoma at this site are poorly defined.
Payne, William D, Jorgensen, Jeffrey L, Khokhar, Faisal A, Talwalkar, Sameer S, Medeiros, L. Jeffrey, Vega, Francisco, Bueso-Ramos, Carlos E   +6 more
core   +1 more source

Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas

Leukemia Research Reports
T-cell lymphomas are aggressive neoplasms characterized by poor responses to current chemotherapeutic agents. Expression of the l-type amino acid transporter 1 (LAT 1, SLC7A5) allows for the expansion of healthy T-cell counterparts, and upregulation of ...
Carlos Murga-Zamalloa, Shaun Webb, John Reneau, Alejandro Zevallos, Pierina Danos-Diaz, Vanessa Perez-Silos, Mirna Rodriguez, Guangyao Gao, Wolf-Nicolas Fischer, Bernd Jandeleit, Ryan Wilcox   +10 more
doaj   +1 more source

Leukaemic relapse of angioimmunoblastic T‐cell lymphoma [PDF]

British Journal of Haematology, 2020
Keir Pickard, Chris Williams, Helen Watson, Andrew McGregor   +3 more
openaire   +3 more sources

Survival of patients with angioimmunoblastic T-cell lymphoma. OS (A) and DSS (B).

, 2014
Survival of patients with angioimmunoblastic T-cell lymphoma. OS (A) and DSS (B).
Peng Liu (120506), Bei Xu (62516)
core   +1 more source